The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...

A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...

Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

RNA-seq and spatial transcriptomics showed immune cell subsets that drive kidney and lung complications in systemic sclerosis ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive ...

For some trees, wasted bark is a potential treasure-trove of biopharmaceuticals—from anti-inflammatories to cancer-fighting ...